Yes 2019 is likely to be a standout year for Moy. It would be nice to get an early update from management on how the company is tracking.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025